Published in Magn Reson Med on December 01, 2007
Three-dimensional fabrication at small size scales. Small (2010) 1.31
Applications of molecular MRI and optical imaging in cancer. Future Med Chem (2010) 0.92
Three-dimensional chemical patterns for cellular self-organization. Angew Chem Int Ed Engl (2011) 0.82
Biofriendly bonding processes for nanoporous implantable SU-8 microcapsules for encapsulated cell therapy. J Microencapsul (2011) 0.81
HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell (2007) 4.81
MRI of the tumor microenvironment. J Magn Reson Imaging (2002) 2.87
Choline metabolism in malignant transformation. Nat Rev Cancer (2011) 2.85
Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med (2013) 2.74
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res (2004) 2.43
Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res (2005) 2.32
Tetherless thermobiochemically actuated microgrippers. Proc Natl Acad Sci U S A (2009) 2.18
Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem (2003) 2.12
Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res (2003) 2.05
Surface tension-driven self-folding polyhedra. Langmuir (2007) 1.91
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
3D printed bionic ears. Nano Lett (2013) 1.80
Fabrication of a cylindrical display by patterned assembly. Science (2002) 1.80
RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res (2005) 1.77
MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med (2003) 1.76
Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia (2004) 1.70
Self-propelled nanotools. ACS Nano (2012) 1.65
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res (2010) 1.65
Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn (2006) 1.54
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Res (2008) 1.52
Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res (2006) 1.41
Microassembly based on hands free origami with bidirectional curvature. Appl Phys Lett (2009) 1.38
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm (2006) 1.37
Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography. Cancer Res (2010) 1.32
Three-dimensional fabrication at small size scales. Small (2010) 1.31
Self-assembled three dimensional radio frequency (RF) shielded containers for cell encapsulation. Biomed Microdevices (2005) 1.28
Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells. Cancer Res (2007) 1.27
Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft. Cancer Res (2009) 1.27
Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res (2003) 1.26
Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. PLoS One (2012) 1.25
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci U S A (2011) 1.24
Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid. J Magn Reson (2013) 1.23
Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol (2011) 1.22
Thin film stress driven self-folding of microstructured containers. Small (2008) 1.21
Spatially controlled chemistry using remotely guided nanoliter scale containers. J Am Chem Soc (2006) 1.18
Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol (2004) 1.17
Self-folding devices and materials for biomedical applications. Trends Biotechnol (2011) 1.16
Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res (2005) 1.15
Enzymatically triggered actuation of miniaturized tools. J Am Chem Soc (2010) 1.15
Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Mol Cancer Res (2007) 1.14
PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach. Magn Reson Med (2008) 1.13
Hypoxic tumor microenvironments reduce collagen I fiber density. Neoplasia (2010) 1.12
Self-assembly of lithographically patterned nanoparticles. Nano Lett (2009) 1.12
Nanoscale origami for 3D optics. Small (2011) 1.11
Remote radio-frequency controlled nanoliter chemistry and chemical delivery on substrates. Angew Chem Int Ed Engl (2007) 1.10
Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia (2009) 1.10
Kinetics of ultraviolet and plasma surface modification of poly(dimethylsiloxane) probed by sum frequency vibrational spectroscopy. Langmuir (2006) 1.09
Self-folding polymeric containers for encapsulation and delivery of drugs. Adv Drug Deliv Rev (2012) 1.09
3D lithographically fabricated nanoliter containers for drug delivery. Adv Drug Deliv Rev (2007) 1.09
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging (2005) 1.08
Differentially photo-crosslinked polymers enable self-assembling microfluidics. Nat Commun (2011) 1.08
Self-folding micropatterned polymeric containers. Biomed Microdevices (2011) 1.08
Collagen I fiber density increases in lymph node positive breast cancers: pilot study. J Biomed Opt (2012) 1.08
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev (2010) 1.06
Biopsy with thermally-responsive untethered microtools. Adv Mater (2012) 1.06
Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. NMR Biomed (2010) 1.03
Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. Neoplasia (2007) 1.02
Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods. Proc IEEE Inst Electr Electron Eng (2005) 1.02
Image-guided enzyme/prodrug cancer therapy. Clin Cancer Res (2008) 1.01
Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. ACS Nano (2010) 1.01
Biomimetic self-assembly of a functional asymmetrical electronic device. Proc Natl Acad Sci U S A (2002) 1.01
Biopsy using a magnetic capsule endoscope carrying, releasing, and retrieving untethered microgrippers. IEEE Trans Biomed Eng (2014) 1.01
Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype. Cancer Res (2006) 1.00
Hypoxia increases breast cancer cell-induced lymphatic endothelial cell migration. Neoplasia (2008) 1.00
Molecular-functional imaging of cancer: to image and imagine. Trends Mol Med (2007) 1.00
Molecular and functional imaging of cancer: advances in MRI and MRS. Methods Enzymol (2004) 1.00
Choline kinase alpha in cancer prognosis and treatment. Lancet Oncol (2007) 0.99
Micropatterned agarose gels for stamping arrays of proteins and gradients of proteins. Proteomics (2004) 0.99
Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR Biomed (2012) 0.99
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol (2010) 0.98
Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells. Neoplasia (2006) 0.97
Directed growth of fibroblasts into three dimensional micropatterned geometries via self-assembling scaffolds. Biomaterials (2010) 0.96
Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin. Magn Reson Med (2002) 0.96
Contributing factors of temozolomide resistance in MCF-7 tumor xenograft models. Cancer Biol Ther (2007) 0.95
Multimodal image-guided enzyme/prodrug cancer therapy. J Am Chem Soc (2006) 0.95
Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells. Neoplasia (2009) 0.94
Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2. Cancer Biol Ther (2009) 0.94
Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res (2012) 0.94
Multiscale imaging and computational modeling of blood flow in the tumor vasculature. Ann Biomed Eng (2012) 0.94
Algorithmic design of self-folding polyhedra. Proc Natl Acad Sci U S A (2011) 0.94